AI MARKET SCANNING

Enanta Pharmaceuticals Inc

📅 Next Catalyst: Nov 16, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.54%
MAX GAP RECORD +13.68%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ENTA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 16, 2026 Earnings Release 2026-11-16 (AFTER CLOSE) 🔮 UPCOMING 🔒
Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE)
-0.51%
May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE)
-5.60%
Feb 09, 2026 Earnings Release 2026-02-09 (AFTER CLOSE)
+9.33%
Nov 17, 2025 Earnings Release 2025-11-17 (AFTER CLOSE)
-4.68%
Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE)
+1.54%
May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE)
-0.72%
Feb 10, 2025 Earnings Release 2025-02-10 (AFTER CLOSE)
+7.14%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.6%
Bullish Gaps (5)
Bearish Gaps (7)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ENTA

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗